A review of clinical data on amyloid-targeting Alzheimer’s therapies has found absent or trivial efficacy, but is facing pushback from some experts.
Abridge is partnering with top medical journals to bring in research for doctors to refer to during visits, pitting it against medical search giant OpenEvidence
The FDA is taking the first step toward potentially backing popular peptides, convening advisors to discuss whether a handful of products should be given the
The XBI is up 30% in six months, beating the S&P 500 by 24 percentage points — and the gap only widened in April.
In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.
Freya Biosciences is moving a microbial immunotherapy for IVF implantation failure into mid-stage trials after promising results in healthy volunteers.
The Phase 2 study is testing Freya’s candidate, called FB301, in women with vaginal dysbiosis …
Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844